Free Trading + Demat Account

Eris Lifesciences Limited IPO (Eris Lifesciences IPO) Detail

Jun 16, 2017 - Jun 20, 2017

Incorporated in 2007, Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris product portfolio is primarily focused on therapeutic areas which require the intervention of super specialist and specialist doctors such as Diabetologists, Endocrinologists Cardiologists, and Gastroenterologists.

Eris products in the chronic category cater primarily to the therapeutic areas including cardiovascular, anti-diabetics and neurology, chronic respiratory and chronic pain (analgesics).

In acute category, the product portfolio includes vitamins, gastroenterology, anti-infectives, gynaecology, cute respiratory, acute pain (analgesics), hepatoprotectives, hormones, hematology, dermatology, anti-obesity products and products for injury healing.

Eris Lifescience own and operate a manufacturing facility in Guwahati, Assam. They also outsource the manufacturing of certain of its products to 20 manufacturers. Eris strong sales team comprised of 1,310 marketing representatives.

Eris Lifescience Strengths:

• Focus on branded prescription based pharmaceutical products catering to lifestyle related disorders
• Portfolio of high volume and leading brands
• Focus on metro cities and class 1 towns in India which have higher incidence of lifestyle disorders and concentration of specialists and super specialists
• Multi-faceted product selection and engagement model leading to growth in prescription
• Strong sales, marketing and distribution capabilities

Company Promoters:

The Promoters of the Company are:
1. Mr. Amit Indubhushan Bakshi,
2. Mr. Himanshu Jayantbhai Shah,
3. Mr. Inderjeet Singh Negi,
4. Mr. Rajendrakumar Rambhai Patel and
5. Mr. Kaushal Kamlesh Shah.

Company Financials:

Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63

Objects of the Issue:

The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of up to 28,875,000 Equity Shares by the Selling Shareholders.

Issue Detail:

  »»  Issue Open: Jun 16, 2017 - Jun 20, 2017
  »»  Issue Type: Book Built Issue IPO
  »»  Issue Size: 28,875,000 Equity Shares of Rs 1 aggregating up to Rs 1,741.16 Cr
    ›  Offer for Sale of 28,875,000 Equity Shares of Rs 1 aggregating up to Rs [.] Cr
  »»  Face Value: Rs 1 Per Equity Share
  »»  Issue Price: Rs 600 - Rs 603 Per Equity Share
  »»  Market Lot: 24 Shares
  »»  Minimum Order Quantity: 24 Shares
  »»  Listing At: BSE, NSE

Discount to eligible employees

Eris Lifesciences is offering discount of ₹60 per share to eligible employees.

Eris Lifesciences IPO Reviews:

  1. Eris Lifesciences Limited IPO review by Dilip Davda

Eris Lifesciences IPO Recommendations:

Capital Market Review
Hem Securities - Subscribe
Angel Broking - Subscribe
ICICIDirect - Subscribe
SP Tulsian - Subscribe
Choice Equity Broking - Avoid

Issue Subscription Detail / Current Bidding Status

Number of Times Subscribed (BSE + NSE)
As on Date & TimeQIBNIIRIIEmployeeTotal
Shares Offered / Reserved8,617,5004,308,7502,872,500150,00015,948,750
Day 1 - Jun 16, 2017 17:00 IST0.07000.02000.41000.00000.1200
Day 2 - Jun 19, 2017 17:00 IST0.82000.03001.68000.33000.7500
Day 3 - Jun 20, 2017 17:00 IST4.68000.45003.51000.86003.2900

Eris Lifesciences IPO Prospectus

Eris Lifesciences IPO Rating

Rating:Rated 4.0 stars

Vote Here ...

Eris Lifesciences IPO Listing Date

  •   ›  Listing Date: Thursday, June 29, 2017
  •   ›  BSE Script Code: 540596
  •   ›  NSE Symbol: ERIS
  •   ›  Listing In: ‘B’ Group of Securities
  •   ›  ISIN: INE406M01024
  •   ›  Issue Price: Rs 603 Per Equity Share
  •   ›  Face Value: Rs 1 Per Equity Share

Listing Day Trading Information

Issue Price:
Last Trade:
Rs 603.00
Rs 612.00
Rs 592.30
Rs 627.70
Rs 601.05
Rs 603.00
Rs 611.00
Rs 593.25
Rs 628.00
Rs 601.50

Eris Lifesciences IPO News Alerts

  1. Thursday, June 29, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Listing
  2. Saturday, June 24, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Allotment
  3. Tuesday, June 20, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Close
  4. Friday, June 16, 2017 12:00:00 AM
    Eris Lifesciences Limited IPO - Open

Company Contact Information

Eris Lifesciences Limited
7th Floor, Commerce House IV,
Beside Shell Petrol Pump, 100 Feet Road,
Prahladnagar, Ahmedabad 380 015
Phone: +91 79 3045 1111
Fax: +91 79 3017 9404

Eris Lifesciences IPO Registrar

Link Intime India Private Ltd   »  Report
   Link Intime India Private Ltd,
   C-13 Pannalal Silk Mills Compound,
   LBS Marg, Bhandup West, Mumbai 400078

Phone: +91-22-25963838
Fax: +91-22-25946969

Guaranteed Save 60% to 90% Brokerage + Taxes

Do you know you could reduce the brokerage cost significantly by moving to another stock broker? Our expert team compared top share brokers in India to help investors like you. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.

We can help you choosing the right broker. Contact us today...


Eris Lifesciences IPO Review / Comments

585. ipobazaar  Aug 11, 2017 10:53:35 AM IST I Like It. | Report Abuse
very poor listing....thats why GMP never guide please dont blame on market condition..SiS was listed yesterday and atleast opened on higher notes not like cochin shipyard...
i am lucky that i did not get allotment in shipyard...lets see what happens after listing...
584. VINAYERH  Aug 9, 2017 8:27:06 PM IST I Like It. | Report Abuse
Chek for AFHPK6980P
583. ASNI  Aug 8, 2017 6:52:17 PM IST I Like It. | Report Abuse
583.1. Compounder  Aug 9, 2017 2:39:19 AM IST I Like It. 1 | Report Abuse
Decision to sell or hold depends on your holding period. On a v conservative basis, expect the next 3 year CAGR growth to be @ 25% (2017 PAT growth was 79%) which will take the EPS to Rs. 34.3 per share. Even at a P/E multiple of 35 (reasonable for a company with 25% earnings growth and secular domestic consumption story), this stock will be at minimum Rs. 1200 by FY 20. That''s a whopping 117% return from the current price. If this return does not satisfy some people, not sure what does. This is a long term coumpounding machine run by owner operator who has skin in the game. Just hold tight for the next 2 quarters at least till the results are out and see the magic.
582. Ajmera  Aug 5, 2017 7:35:51 PM IST I Like It. | Report Abuse
target may be appox. 940-1000 in 3-4 month
581. Tarun D Agrawal  Jul 30, 2017 5:53:42 PM IST I Like It. | Report Abuse
Will the share price go up?
581.1. Mr. Ghosh  Jul 30, 2017 6:27:17 PM IST I Like It. | Report Abuse
Wait for few days.
580. RT  Jul 26, 2017 10:20:04 PM IST I Like It. | Report Abuse
Eris and Laurus both are going down.
579. DSR  Jul 25, 2017 12:16:13 AM IST I Like It. | Report Abuse
Top Contributor Top Contributor (200+ Posts, 200+ Likes)
This is now close to open price. I believe for those wh did not get allotment now is the god time t buy or ..should wait more for the market to correct...secondary market has become too risky ..
578. SACHIN MEHTA  Jul 19, 2017 5:58:29 PM IST I Like It. | Report Abuse
Hello Sapta Sir and Eagle eye Mam...Please suggest me about Eris Lifescience..Whether we hold or sell the stock..and if hold how much time to hold for good return...and what is your views on this stock?
578.1. Raynmaker  Jul 19, 2017 6:17:27 PM IST I Like It. | Report Abuse
Wait till the first result, minimum.
577. Compounder  Jul 16, 2017 3:14:01 AM IST I Like It. | Report Abuse
576. Dn  Jul 14, 2017 1:54:05 PM IST I Like It. | Report Abuse
Bought 50 shares@714 & another 50 shares @ 702
Hold or sell
576.1. Prem Nookala  Jul 14, 2017 6:19:59 PM IST I Like It. | Report Abuse
It''s a good equity fundamentally. You could go for longterm.
575. nicks Jain  Jul 14, 2017 11:49:29 AM IST I Like It. | Report Abuse
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
Definitely good Stocks to keep in Portfolio.
Its only for long term investors....
574. wow  Jul 14, 2017 10:08:12 AM IST I Like It. | Report Abuse
its zooming now
573. AHM  Jul 13, 2017 10:26:02 PM IST I Like It. | Report Abuse
Eris Life science Fundamentally Good company
One can continue to hold for ST/MT.

Tomorrow again we will upside
Today closing price 676.95
572. RT  Jul 13, 2017 8:39:18 PM IST I Like It. 1 | Report Abuse
I am Eris Lifesciences and now my turn to show the game.
571. BestAnalyst  Jul 6, 2017 9:17:15 PM IST I Like It. | Report Abuse
Eris is not moving ... And tejas is running like a horse.
571.1. Raynmaker  Jul 13, 2017 4:48:19 PM IST I Like It. 1 | Report Abuse
Check now
571.2. nicks Jain  Jul 13, 2017 5:13:24 PM IST I Like It. 2 | Report Abuse
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
In Equity mkt, lots of patience Needed
Just Like in ERIS,we were sure and confident to keep hold
570. nicks Jain  Jul 13, 2017 5:06:04 PM IST I Like It. 3 | Report Abuse
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
Eris rocks today
Still holding 7 lots of IPO
569. Raynmaker  Jul 13, 2017 4:38:49 PM IST I Like It. 1 | Report Abuse
37 L shares traded today and Closed At 696, up 12.6%. Where are the people who were waiting to buy at 550-570?
@Septa ji profits Mubarak ho.
I am still holding and will not sell below 1,000
568. Raynmaker  Jul 6, 2017 8:52:44 AM IST I Like It. | Report Abuse
Delivery volume since last two days over 50%. Yesterday jumped to 62%
568.2. Raynmaker  Jul 6, 2017 3:00:13 PM IST I Like It. | Report Abuse
Now that AU allocation is out and funds will be released, let''s see how this one behaves. Allocation has been low in HNI
568.3. Raynmaker  Jul 11, 2017 4:41:37 PM IST I Like It. | Report Abuse
Hit a High of 632. It was magical. Just zoomed and zoomed and zoomed. Still holding, wont let go below 1,000, whatever time it takes.
567. DSR  Jul 9, 2017 9:52:23 PM IST I Like It. | Report Abuse
Top Contributor Top Contributor (200+ Posts, 200+ Likes)
One off track question:

I am using HDFsec for trading: My demat account, trading and savings account all are with HDFC.

I am now thinking of opening demat account for my wife. Could anyone suggest where should I open it ? And would it be possible to use the new account for trading through HDFCsec?
566. Chem cho  Jun 29, 2017 11:19:16 AM IST I Like It. 7 | Report Abuse
IPO Guru IPO Guru (1500+ Posts, 900+ Likes)
Good buy at Rs 560 to Rs 570
wait and watch
I always come on site at time of listing ,
where experts do not dare to give comments from 10 am to 3 pm

bye no more time to spare in this site
566.13. Maniac  Jul 5, 2017 5:58:13 PM IST I Like It. 1 | Report Abuse
@ Shareview

Thanks mate ...:)
566.14. Raynmaker  Jul 13, 2017 11:21:29 AM IST I Like It. 1 | Report Abuse
Chem cho did you buy any at 560-570?
By Popular Stock Brokers

Flat 20 Per Trade
Free Equity Delivery Trades

100% brokerage refund if in 60 days you have made net profits

Enquire Now
(* on online account opening)

Leading Retail Broker in India

Rs 0 account opening fee on Demat Acct + 20% OFF on online trading

Request Instant Call Back

ProStocks Reivew
    Flat Fee Discount Broker

Rs 899 Unlimited Equity
Rs 499 Unlimited Curr
or Rs 15 per Trade

Lowest Transaction Charge
Lowest Call & Trade Fee
Lowest Stamp Duty

FREE Trading + Demat Acct

Beginner, seasoned investor, active trader or HNI. Get customised solutions.

Rs 0 account opening fee on Online Trading + Demat Acct
(Rs 1150 waived)

Request Call Back

More About Brokers

Special Offers Broker Reports

Message Board

Stock Message Board